Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.

Source:http://linkedlifedata.com/resource/pubmed/id/19854549

Download in:

View as

General Info

PMID
19854549